CKS-17

Modify Date: 2024-01-02 16:26:42

CKS-17 Structure
CKS-17 structure
Common Name CKS-17
CAS Number 99273-04-8 Molecular Weight 1942.27000
Density 1.41±0.1 g/cm3 (20 °C, 760 mmHg) Boiling Point N/A
Molecular Formula C87H148N26O24 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CKS-17


CKS-17 is a synthetic retroviral envelope peptide. CKS-17 has the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 acts as an immunomodulatory epitope and exhibits suppressive properties for numerous immune functions[1][2][3].

 Names

Name L-Leucine, L-leucyl-L-glutaminyl-L-asparaginyl-L-arginyl-L-arginylglycyl-L-leucyl-L-α-aspartyl-L-leucyl-L-leucyl-L-phenylalanyl-L-leucyl-L-lysyl-L-α-glutamylglycylglycyl
Synonym More Synonyms

 CKS-17 Biological Activity

Description CKS-17 is a synthetic retroviral envelope peptide. CKS-17 has the highly conserved amino acid sequences occurring within the transmembrane envelope protein of many animal and human retroviruses. CKS-17 acts as an immunomodulatory epitope and exhibits suppressive properties for numerous immune functions[1][2][3].
Related Catalog
In Vitro CKS-17 (THP-1 cells) induces increased intracellular cAMP via activation of adenylate cyclase[1]. CKS-17 (15 μM; EL4 cells) inhibits interleukin-2 production by tumor cell products[3].
In Vivo CKS-17 (10 μM; i.d.; B6AF1 mice and C57BL/6J mice) inhibits delayed-type hypersensitivity (DTH) reactions to sheep erythrocytes in the feet of mice[2]. Animal Model: B6AF1 mice and C57BL/6J mice with DTH models[2] Dosage: 10 μM Administration: Intradermal injection, into the right hind footpad Result: Had a transient depressive effect on DTH reaction.

 Chemical & Physical Properties

Density 1.41±0.1 g/cm3 (20 °C, 760 mmHg)
Molecular Formula C87H148N26O24
Molecular Weight 1942.27000
Exact Mass 1941.12000
PSA 839.52000
LogP 5.14200

 Synonyms

1067: PN: US20090175821 SEQID: 1339 claimed protein
CKS-17